167 related articles for article (PubMed ID: 4136728)
1. Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.
Lassen JB
Psychopharmacologia; 1974; 37(4):331-40. PubMed ID: 4136728
[No Abstract] [Full Text] [Related]
2. Copulatory behavior in the male rat after impaired monoaminergic neurotransmission.
Malmnäs CO
Acta Physiol Scand Suppl; 1973; 400():69-95. PubMed ID: 4136131
[No Abstract] [Full Text] [Related]
3. Effect of desipramine on rat cortex slices incubated with 3H-dopamine.
Gerlach J; Nielsen M; Randrup A
Psychopharmacologia; 1974; 37(4):341-9. PubMed ID: 4851622
[No Abstract] [Full Text] [Related]
4. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
Andén NE; Corrodi H; Fuxe K
J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
[No Abstract] [Full Text] [Related]
5. Influence of changes in brain monoamine metabolism on behaviour of herpes simplex-infected mice.
Lycke E; Roos BE
J Neurol Sci; 1974 Jul; 22(3):277-89. PubMed ID: 4151982
[No Abstract] [Full Text] [Related]
6. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
Farnebo LO; Hamberger B; Jonsson G
J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
[No Abstract] [Full Text] [Related]
7. Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic alpha-adrenoceptors.
Zebrowska-Lupina I; Przegalinski E; Sloniec M; Kleinrok Z
Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):227-31. PubMed ID: 69273
[TBL] [Abstract][Full Text] [Related]
8. Actions of dopaminergic antagonists in the striatum.
Sedvall G; Fyrö B; Nybäck H; Wiesel FA
Adv Neurol; 1975; 9():131-40. PubMed ID: 238375
[No Abstract] [Full Text] [Related]
9. The acute effect of timiperone on the alpha-MT-induced dopamine fluorescence in rat brain.
Kojima H; Suetake K; Tsutsumi T; Anraku S; Inanaga K
Kurume Med J; 1982; 29(2):93-5. PubMed ID: 6132022
[No Abstract] [Full Text] [Related]
10. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
Khalsa JH; Davis WM
J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
[No Abstract] [Full Text] [Related]
11. Drug-induced changes in brain tyrosine hydroxylase activity in vivo.
Leonard BE
Neuropharmacology; 1977 Jan; 16(1):47-52. PubMed ID: 13325
[No Abstract] [Full Text] [Related]
12. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
Ahlenius S
Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
[No Abstract] [Full Text] [Related]
13. Inhibition of catecholamine synthesis during ontogenic development.
Kellogg C; Lundborg P
Brain Res; 1973 Oct; 61():321-9. PubMed ID: 4149305
[No Abstract] [Full Text] [Related]
14. Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, alpha-dimethyl-m-tyramine (H 77/77) in rats.
Lassen JB
Psychopharmacology (Berl); 1977 Oct; 54(2):153-7. PubMed ID: 144928
[TBL] [Abstract][Full Text] [Related]
15. The role of hypothalamic adrenergic receptors in preventing testosterone-induced androgenization in the female rat brain.
Raum WJ; Swerdloff RS
Endocrinology; 1981 Jul; 109(1):273-8. PubMed ID: 6113131
[TBL] [Abstract][Full Text] [Related]
16. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
Rolinski Z; Scheel-Krüger J
Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
[No Abstract] [Full Text] [Related]
17. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
Andén NE; Butcher SG; Corrodi H; Fuxe K; Ungerstedt U
Eur J Pharmacol; 1970; 11(3):303-14. PubMed ID: 5477307
[No Abstract] [Full Text] [Related]
18. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
Hollister AS; Breese GR; Cooper BR
Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
[No Abstract] [Full Text] [Related]
19. The relative functional availability of brain noradrenaline and dopamine storage pools.
McMillen BA; Shore PA
J Pharm Pharmacol; 1977 Dec; 29(12):780-1. PubMed ID: 22634
[No Abstract] [Full Text] [Related]
20. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
Andén NE; Strömbom U
Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
